Long-lasting consequences of coronavirus disease 19 pneumonia: a systematic review.


Journal

Minerva medica
ISSN: 1827-1669
Titre abrégé: Minerva Med
Pays: Italy
ID NLM: 0400732

Informations de publication

Date de publication:
Feb 2022
Historique:
pubmed: 4 12 2021
medline: 24 3 2022
entrez: 3 12 2021
Statut: ppublish

Résumé

Coronavirus disease 19 (COVID-19) is an infectious disease caused by the newly discovered severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We have plenty of data about the clinical features of the disease's acute phase, while little is known about the long-term consequences on survivors. We aimed to review systematically emerging evidence about clinical and functional consequences of COVID-19 pneumonia months after hospital discharge. Current evidence supports the idea that a high proportion of COVID-19 survivors complain of symptoms months after the acute illness phase, being fatigue and reduced tolerance to physical effort the most frequently reported symptom. The strongest association for these symptoms is with the female gender, while disease severity seems less relevant. Respiratory symptoms are associated with a decline in respiratory function and, conversely, seem to be more frequent in those who experienced a more severe acute pneumonia. Current evidence highlighted a persistent motor impairment which is, again, more prevalent among those survivors who experienced a more severe acute phase of the disease. Additionally, the persistence of symptoms is a primary determinant of mental health outcome, with anxiety, depression, sleep disturbances, and post-traumatic stress symptoms being commonly reported in COVID-19 survivors. Current literature highlights the importance of a multidisciplinary approach to Coronavirus Disease 19 since the sequelae appear to involve different organs and systems. Given the pandemic outbreak's size, this is a critical public health issue: a better insight on this topic should inform clinical decisions about the modalities of follow-up for COVID-19 survivors.

Identifiants

pubmed: 34856780
pii: S0026-4806.21.07594-7
doi: 10.23736/S0026-4806.21.07594-7
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

158-171

Auteurs

Filippo Patrucco (F)

Department of Pneumology, Ospedale Maggiore della Carità University Hospital, Novara, Italy.

Patrizia Zeppegno (P)

Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Psychiatry Department, Ospedale Maggiore della Carità University Hospital, Novara, Italy.

Alessio Baricich (A)

Department of Health Sciences, Eastern Piedmont University, Novara, Italy - alessio.baricich@med.uniupo.it.
Department of Physical and Rehabilitation Medicine, Ospedale Maggiore della Carità University Hospital, Novara, Italy.

Carla M Gramaglia (CM)

Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Psychiatry Department, Ospedale Maggiore della Carità University Hospital, Novara, Italy.

Piero E Balbo (PE)

Department of Pneumology, Ospedale Maggiore della Carità University Hospital, Novara, Italy.

Zeno Falaschi (Z)

Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Department of Radiology, Ospedale Maggiore della Carità University Hospital, Novara, Italy.

Alessandro Carriero (A)

Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Department of Radiology, Ospedale Maggiore della Carità University Hospital, Novara, Italy.

Daria Cuneo (D)

Department of Health Sciences, Eastern Piedmont University, Novara, Italy.
Department of Physical and Rehabilitation Medicine, Ospedale Maggiore della Carità University Hospital, Novara, Italy.

Mario Pirisi (M)

Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Department of Internal Medicine, Ospedale Maggiore della Carità University Hospital, Novara, Italy.

Mattia Bellan (M)

Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Department of Internal Medicine, Ospedale Maggiore della Carità University Hospital, Novara, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH